Merck KGaA CFO Helene von Roeder discusses the group's third-quarter earnings and its progress with drug trials.

US stock futures edged higher Thursday ahead of a highly-anticipated speech by Fed chair Jerome Powell, which could provide ...

Merck , known as MSD outside of the United States and Canada, and LaNova Medicines Ltd. (LaNova), a privately held clinical-stage biotechnology company, today announced that Merck has entered into an ...

Merck & Co. licensed an experimental cancer antibody from a closely held Chinese company in a deal worth $588 million upfront ...

Each year, 500 to 1,000 people in the U.S. are diagnosed with pulmonary arterial hypertension (PAH), a progressive and often under-detected disease. To address the significant impact of this disease ...

Merck posted sales of 5.17 billion euros in the prior-year quarter ... ([email protected]) 2123 ET – Hartalega Holdings may be able to raise its average selling prices by US$1-US$2 per 1,000 gloves ...

A subcutaneous version of Daiichi Sankyo’s AstraZeneca-partnered blockbuster antibody-drug conjugate (ADC) Enhertu could be ...

Updated clinical data from VISTA101 presented at SITC 2024.Monotherapy arm fully enrolled and combination arm expected to be fully enrolled by ...

At study sites in Seattle, San Diego, and Birmingham, Alabama, recruiters are collectively enrolling 4,000 participants, with inclusion criteria promoting balance: race/ethnicity (1,000 each ...

Investors have been hesitant to buy Merck largely due to its dependence on cancer drug ... And the numbers speak for themselves: Amazon: if you invested $1,000 when we doubled down in 2010, you’d have ...

On rare occasions, our expert team of analysts issues a “Double Down” stock recommendation for companies that they think are about to pop. If you’re worried you’ve already missed your chance to invest ...

Dan Quick’s legislative campaign has received $257,289.23 in donations in 2024, while Ray Aguilar’s campaign has brought in ...